Sanne van den Berg
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 24, 2026
The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions.Sanne van den Berg, Marie Attwood, Pippa Griffin
|Mar 17, 2026
The pharmacodynamics of polymyxin B in Acinetobacter baumannii in murine thigh and lung infection models.Sanne van den Berg, Michel Pieren, Sebastiaan D T Sassen
|Mar 04, 2025
The synergistic effect of the combination of polymyxin B and rifampicin in a murine neutropenic thigh infection model with E. coli and K. pneumoniae.Sanne Van Den Berg, Sebastiaan D T Sassen, William Couet
|Jan 13, 2025
Pharmacodynamics of NOSO-502 studied in vitro and in vivo: determination of the dominant pharmacodynamic index driver.Sanne van den Berg, Marie G L Attwood, Pippa Griffin
|Jan 31, 2023
Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models.Aart van der Meijden, Vincent Aranzana-Climent, Heleen van der Spek
|Aug 26, 2022
Pharmacodynamics of Flucloxacillin in a Neutropenic Murine Thigh Infection Model: A Piece of the Puzzle towards Evidence-Based Dosing.Eveline E Roelofsen, Brenda C M de Winter, Heleen van der Spek
Pageof 1
